<DOC>
	<DOCNO>NCT02095418</DOCNO>
	<brief_summary>With improvement patient graft survival , increase attention place complication contribute long-term patient morbidity mortality . New-onset diabetes transplantation ( NODAT ) common complication solid-organ transplantation , strong predictor graft failure cardiovascular mortality transplant population . Risk factor NODAT transplant recipient similar non-transplant patient , transplant-specific risk factor hepatitis C ( HCV ) infection , corticosteroid calcineurin inhibitor play dominant role NODAT pathogenesis . The predominant factor cause NODAT corticosteroid seem aggravation insulin resistance ; however several study display deleterious effect insulin secretion β-cells . Thus , adjust immunosuppressant regimen improve glucose tolerance must measure define long term perspective . As recipient organ transplant survive long , complication NODAT assume great importance ; therefore , design prospective study compare safety efficacy early versus late withdrawal corticosteroid liver transplantation .</brief_summary>
	<brief_title>Comparison New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1.Male female patient 2070 year 2.De novo patient 3.Recipients live cadaveric donor 4.Single organ recipient ( liver ) 5.White Blood Cell ( WBC ) ≥ 3,000uL 6.Women childbearing potential negative serum urine pregnancy test within 1 week prior begin study treatment . Effective contraception use begin therapy , therapy 6 week follow discontinuation therapy 7.Patients cooperative able complete assessment procedure . 8.Patients provide write informed consent 1 . Patients receive immunosuppressive therapy ( except steroid treatment ) within precede 28 day . 2 . Incompatible A , B , O blood group system . 3 . Active infection 4 . Patients whose laboratory result reveal severe anaemia ( define haemoglobin value &lt; 9 g/dL adult receive erythropoietin , 6.5 g/dL adult receive erythropoietin , leukopenia ( define white blood cell [ WBC ] value &lt; 1500/mm3 ) thrombocytopenia ( defined platelet count &lt; 30,000/mm3 ) . 5 . Mandatory intake prohibit drug probable patient would require treatment drug transplant 6 . Patient allergic intolerant excipients , steroid , Mycophenolate mofetil ( MMF ) , tacrolimus basiliximab . 7 . Patients form substance abuse , psychiatric disorder condition , , opinion investigator , may invalidate communication investigator study procedure . 8 . The receipt new investigational drug within previous 3 month 9 . Pregnant lactating female . 10 . Women childbearing potential willing use reliable form contraception . 11 . Previous organ transplantation 12 . Patients diabetes mellitus prior transplantation 13 . Patients cancer liver cancer 14 . Patients HGPRT ( hypoxanthine quinine phosphoribosyl transferase ) deficiency , LeschNyhan syndrome , KellySeegmiller syndrome</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>New-onset diabetes transplantation ( NODAT )</keyword>
	<keyword>Liver transplantation</keyword>
</DOC>